Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar

Wound Repair and Regeneration

Volumn 15, Issue SUPPL. 1, 2007, Pages

  Ghahary, Aziz ^a,b   Ghaffari, Abdi ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS; PROTEIN C JUN;

AUTOCRINE EFFECT; CELL GROWTH; CELL INTERACTION; COCULTURE; CYTOKINE PRODUCTION; DIABETES MELLITUS; ELECTRIC INJURY; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HYPERTROPHIC SCAR; IMMUNOCOMPETENT CELL; KERATINOCYTE; MESENCHYME CELL; MOLECULAR MECHANICS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SURGICAL WOUND; THERMAL INJURY; THROMBOCYTE; TISSUE REPAIR; WOUND HEALING;

CELL COMMUNICATION; CICATRIX, HYPERTROPHIC; FIBROBLASTS; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASES; WOUND HEALING;

EID: 34548136162     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2007.00225.x     Document Type: Review

References (67)

1. Iocono JA, Ehrlich HP. The biology of healing. In: Leaper DJ, Harding KG, editors. Wounds: biology and management. Oxford: Oxford University Press, 1998: 10 22.
2. Berton G, Laudanna C, Sorio C, Rossi F. Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils. J Cell Biol 1992 116: 1007 17.
3. Hunt TK, Hussain Z. Wound microenvironment. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical & clinical aspects. Philadelphia: W.B. Saunders Company, 1992: 274 81.
4. Stein JM, Levenson SM. Effect of the inflammatory reaction on subsequent wound healing. Surg Forum 1966 17: 484 5.
5. Leibovich SJ, Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975 78: 71 100.
6. Barbul A. Role of the immune system. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical & clinical aspects. Philadelphia: W.B. Saunders Company, 1992: 282 91.
7. Robson MC, Heggers JP. Eicosanoids, cytokines, and free radicals. In: Cohen IK, Diegelmann RF, Lindblad WJ, editors. Wound healing: biochemical & clinical aspects. Philadelphia: W.B. Saunders Company, 1992: 292 304.
8. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990 8: 365 400.
9. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Griffin GL, Senior RM, Deuel TF. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989 109: 429 40.
10. Cromack DT, Porras-Reyes B, Mustoe TA. Current concepts in wound healing: growth factor and macrophage interaction. J Trauma 1990 30 (Suppl. 12): S129 33.
11. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 1994 8: 823 31.
12. Terketaub RA, Ginsberg MH. Platelets and response to injury. In: Clark RAF, Hensen PM, editors. The molecular and cellular biology of wound repair. New York: Plenum Press, 1988: 36 55.
13. Nemeth GG, Bolander ME, Martin GR. Growth factors and their role in wound and fracture healing. In: Barbul A, Pines E, Caldwell M, Hunt TK, editors. Growth factors and other aspects of wound healing. New York: A.R. Liss, 1988: 1 17.
14. Coulombe PA. Towards a molecular definition of keratinocyte activation after acute injury to stratified epithelia. Biochem Biophys Res Commun 1997 236: 231 8.
15. Bolivar-Flores J, Poumian E, Marsch-Moreno M, Montes de OG, Kuri-Harcuch W. Use of cultured human epidermal keratinocytes for allografting burns and conditions for temporary banking of the cultured allografts. Burns 1990 16: 3 8.
16. Somers T, Verbeken G, Vanhalle S, Delaey B, Duinslaeger L, Govaerts P, Offeciers E. Lysates from cultured allogeneic keratinocytes stimulate wound healing after tympanoplasty. Acta Otolaryngol 1996 116: 589 93.
17. Duinslaeger L, Verbeken G, Reper P, Delaey B, Vanhalle S, Vanderkelen A. Lyophilized keratinocyte cell lysates contain multiple mitogenic activities and stimulate closure of meshed skin autograft-covered burn wounds with efficiency similar to that of fresh allogeneic keratinocyte cultures. Plast Reconstr Surg 1996 98: 110 7.
18. Eisinger M, Sadan S, Silver IA, Flick RB. Growth regulation of skin cells by epidermal cell-derived factors: implications for wound healing. Proc Natl Acad Sci USA 1988 85: 1937 41.
19. Silver IA, Eisinger M. Influence of an epidermal cell extract on skin healing and scar formation. Int J Tissue React 1988 10: 381 5.
20. Garner WL. Epidermal regulation of dermal fibroblast activity. Plast Reconstr Surg 1998 102: 135 9.
21. Kratz G, Jansson K, Gidlund M, Haegerstrand A. Keratinocyte conditioned medium stimulates type IV collagenase synthesis in cultured human keratinocytes and fibroblasts. Br J Dermatol 1995 133: 842 6.
22. Goulet F, Poitras A, Rouabhia M, Cusson D, Germain L, Auger FA. Stimulation of human keratinocyte proliferation through growth factor exchanges with dermal fibroblasts in vitro. Burns 1996 22: 107 12.
23. Johnson-Wint B. Do keratinocytes regulate fibroblast collagenase activities during morphogenesis? Ann NY Acad Sci 1988 548: 167 73.
24. el-Ghalbzouri A, Gibbs S, Lamme E, Van Blitterswijk CA, Ponec M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol 2002 147: 230 43.
25. El GA, Lamme E, Ponec M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 2002 310: 189 99.
26. Nowinski D, Lysheden AS, Gardner H, Rubin K, Gerdin B, Ivarsson M. Analysis of gene expression in fibroblasts in response to keratinocyte-derived factors in vitro: potential implications for the wound healing process. J Invest Dermatol 2004 122: 216 21.
27. Machesney M, Tidman N, Waseem A, Kirby L, Leigh I. Activated keratinocytes in the epidermis of hypertrophic scars. Am J Pathol 1998 152: 1133 41.
28. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999 274: 21491 4.
29. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993 4: 197 250.
30. Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 1996 106: 476 81.
31. Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I. Matrix metalloproteinases in arthritic disease. Arthritis Res 2002 4 (Suppl. 3): S39 49.
32. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991 64: 327 36.
33. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 2004 16: 558 64.
34. Toole BP. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 2003 54: 371 89.
35. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995 92: 2730 4.
36. Himelstein BP, Canete-Soler R, Bernhard EJ, Muschel RJ. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J Cell Sci 1994 107 (Part 2): 477 86.
37. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990 348: 699 704.
38. DeCastro R, Zhang Y, Guo H, Kataoka H, Gordon MK, Toole B, Biswas G. Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J Invest Dermatol 1996 106: 1260 5.
39. Norgauer J, Hildenbrand T, Idzko M, Panther E, Bandemir E, Hartmann M, Vanscheidt W, Herouy Y. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers. Br J Dermatol 2002 147: 1180 6.
40. van den Oord JJ, Paemen L, Opdenakker G, de Wolf-Peeters C. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 1997 151: 665 70.
41. Varani J, Hattori Y, Chi Y, Schmidt T, Perone P, Zeigler ME, Fader DJ, Johnson TM. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin. Br J Cancer 2000 82: 657 65.
42. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 1992 12: 168 84.
43. Moon SE, Dame MK, Remick DR, Elder JT, Varani J. Induction of matrix metalloproteinase-1 (MMP-1) during epidermal invasion of the stroma in human skin organ culture: keratinocyte stimulation of fibroblast MMP-1 production. Br J Cancer 2001 85: 1600 5.
44. Moon SE, Bhagavathula N, Varani J. Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: regulation through mitogen-activated protein kinase signalling events. Br J Cancer 2002 87: 457 64.
45. Stoll S, Garner W, Elder J. Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 1997 100: 1271 81.
46. Maas-Szabowski N, Stark HJ, Fusenig NE. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 2000 114: 1075 84.
47. Westermarck J, Weiss C, Saffrich R, Kast J, Musti AM, Wessely M, Ansorge W, Seraphin B, Wilm M, Valdez BC, Bohmann D. The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. EMBO J 2002 21: 451 60.
48. Scott PG, Ghahary A, Tredget EE. Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 2000 16: 271 87.
49. Ghahary A, Karimi-Busheri F, Marcoux Y, Li Y, Tredget EE, Taghi KR, Li L, Zheng J, Karami A, Keller BO, Weinfeld M. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 2004 122: 1188 97.
50. Moore BE, Perez VJ. Specific acidic proteins of nervous system. In: Carlson FD, editor. Physiological and biological aspects of nervous integration. Englewood Cliffs, NJ: Prentice-Hall, 1967: 343 59.
51. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3 Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999 401: 616 20.
52. Craparo A, Freund R, Gustafson TA. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem 1997 272: 11663 9.
53. Wilker EW, Grant RA, Artim SC, Yaffe MB. A structural basis for 14-3-3 sigma functional specificity. J Biol Chem 2005 280: 18891 8.
54. Leffers H, Madsen P, Rasmussen HH, Honore B, Andersen AH, Walbum E, Vandekerckhove J, Celis JE. Molecular cloning and expression of the transformation sensitive epithelial marker stratifin. A member of a protein family that has been involved in the protein kinase C signalling pathway. J Mol Biol 1993 231: 982 98.
55. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999 13: 781 92.
56. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 1999 11: 211 8.
57. Lam E, Kilani RT, Li Y, Tredget EE, Ghahary A. Stratifin-induced MMP-1 in fibroblast is mediated by c-fos and p38 MAPK activation. J Invest Dermatol 2005 125: 230 8.
58. Buchwalter G, Gross C, Wasylyk B. Ets ternary complex transcription factors. Gene 2004 324: 1 14.
59. McKenzie RC, Sauder DN. Keratinocyte cytokines and growth factors. Functions in skin immunity and homeostasis. Dermatol Clin 1990 8: 649 61.
60. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004 18: 816 27.
61. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994 331: 1286 92.
62. Border WA, Noble NA. Fibrosis linked to TGF-beta in yet another disease. J Clin Invest 1995 96: 655 6.
63. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000 342: 1350 8.
64. Sporn MB, Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol 1992 119: 1017 21.
65. Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells. Wound Repair Regen 2004 12: 546 56.
66. Ghahary A, Marcoux Y, Karimi-Busheri F, Tredget EE. Keratinocyte differentiation inversely regulates the expression of involucrin and transforming growth factor beta1. J Cell Biochem 2001 83: 239 48.
67. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 2005 124: 170 7.